Only one level mutation, V6A, released in to the molecule significantly improved the toxicity profile and decreased VLS as compared to the WT molecule [76]. Added scientific studies and scientific trials might be essential to determine if this modified construct has enhanced basic safety and efficacy in people.Theoretically, IL-2 has a synergistic